Browse EV MemProt Atlas
Supporting publications (n)
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
EVMP confidence score
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| FZD1 | Q9UP38 | Frizzled-1 (Fz-1) (hFz1) (FzE1) | Cancer-related genesG-protein coupled receptorsPlasma proteins | 7 | Adhesion and uptake mediationReceptor-signaling mediation | 9 | 0.63 | |||
| ICAM1 | P05362 | Intercellular adhesion molecule 1 (ICAM-1) (Major group rhinovirus receptor) (CD antigen CD54) | Cancer-related genesCandidate cardiovascular disease genesCD markers | 1 | Conjunctiva disorderCrohn diseaseIndeterminate colitis | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 9 | 0.63 | ||
| IL2RG | P31785 | Cytokine receptor common subunit gamma (Interleukin-2 receptor subunit gamma) (IL-2 receptor subunit gamma) (IL-2R subunit gamma) (IL-2RG) (gammaC) (p64) (CD antigen CD132) | Cancer-related genesCD markersDisease related genes | 1 | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 9 | 0.63 | |||
| ITA2B | P08514 | Integrin alpha-IIb (GPalpha IIb) (GPIIb) (Platelet membrane glycoprotein IIb) (CD antigen CD41) [Cleaved into: Integrin alpha-IIb heavy chain; Integrin alpha-IIb light chain, form 1; Integrin alpha-IIb light chain, form 2] | Cancer-related genesCandidate cardiovascular disease genesCD markers | 1 | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 9 | 0.63 | |||
| KDF1 | Q8NAX2 | Keratinocyte differentiation factor 1 | Disease related genesHuman disease related genesPredicted intracellular proteins | Fusion and delivery mediation | 9 | 0.63 | ||||
| PPBN | P10696 | Alkaline phosphatase, germ cell type (EC 3.1.3.1) (ALP-1) (Alkaline phosphatase Nagao isozyme) (Alkaline phosphatase, placental-like) (Germ cell alkaline phosphatase) (GCAP) (Placental alkaline phosphatase-like) (PLAP-like) | EnzymesFDA approved drug targetsMetabolic proteins | Clinical-translation mediationMetabolism mediation | 9 | 0.63 | ||||
| SCRIB | Q14160 | Protein scribble homolog (Scribble) (hScrib) (Protein LAP4) | Disease related genesPredicted intracellular proteins | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 9 | 0.63 | ||||
| TNR14 | Q92956 | Tumor necrosis factor receptor superfamily member 14 (Herpes virus entry mediator A) (Herpesvirus entry mediator A) (HveA) (Tumor necrosis factor receptor-like 2) (TR2) (CD antigen CD270) | Cancer-related genesCD markersHuman disease related genes | 1 | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 9 | 0.63 | |||
| ADA10 | O14672 | Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (EC 3.4.24.81) (CDw156) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease) (CD antigen CD156c) | Cancer-related genesCD markersDisease related genes | 1 | Breast cancerSolid tumour/cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 8 | 0.63 | ||
| NIBA1 | Q9BZQ8 | Protein Niban 1 (Cell growth-inhibiting gene 39 protein) (Protein FAM129A) | Cancer-related genesPredicted intracellular proteins | Other mediation | 8 | 0.63 | ||||
| APOBR | Q0VD83 | Apolipoprotein B receptor (Apolipoprotein B-100 receptor) (Apolipoprotein B-48 receptor) (Apolipoprotein B48 receptor) (apoB-48R) | Predicted intracellular proteins | Fusion and delivery mediation | 7 | 0.63 | ||||
| CADM4 | Q8NFZ8 | Cell adhesion molecule 4 (Immunoglobulin superfamily member 4C) (IgSF4C) (Nectin-like protein 4) (NECL-4) (TSLC1-like protein 2) | Predicted membrane proteins | 1 | Adhesion and uptake mediationReceptor-signaling mediation | 7 | 0.63 | |||
| DSC2 | Q02487 | Desmocollin-2 (Cadherin family member 2) (Desmocollin-3) (Desmosomal glycoprotein II) (Desmosomal glycoprotein III) | Disease related genesHuman disease related genesPlasma proteins | 1 | Adhesion and uptake mediationFusion and delivery mediation | 7 | 0.63 | |||
| MUC1 | P15941 | Mucin-1 (MUC-1) (Breast carcinoma-associated antigen DF3) (Cancer antigen 15-3) (CA 15-3) (Carcinoma-associated mucin) (Episialin) (H23AG) (Krebs von den Lungen-6) (KL-6) (PEMT) (Peanut-reactive urinary mucin) (PUM) (Polymorphic epithelial mucin) (PEM) (Tumor-associated epithelial membrane antigen) (EMA) (Tumor-associated mucin) (CD antigen CD227) [Cleaved into: Mucin-1 subunit alpha (MUC1-NT) (MUC1-alpha); Mucin-1 subunit beta (MUC1-beta) (MUC1-CT)] | Cancer-related genesCD markersDisease related genes | 1 | Acute myeloid leukaemiaBipolar disorderBrain cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 7 | 0.63 | ||
| PDE4D | Q08499 | 3',5'-cyclic-AMP phosphodiesterase 4D (EC 3.1.4.53) (DPDE3) (PDE43) (cAMP-specific phosphodiesterase 4D) | Disease related genesEnzymesFDA approved drug targets | Acute upper respiratory infectionAllergic/hypersensitivity disorderAlzheimer disease | Clinical-translation mediationFusion and delivery mediationImmune mediation | 7 | 0.63 | |||
| SRC8 | Q14247 | Src substrate cortactin (Amplaxin) (Oncogene EMS1) | Cancer-related genesPlasma proteinsPredicted intracellular proteins | Adhesion and uptake mediationFusion and delivery mediationReceptor-signaling mediation | 7 | 0.63 | ||||
| UFO | P30530 | Tyrosine-protein kinase receptor UFO (EC 2.7.10.1) (AXL oncogene) | Disease related genesEnzymesFDA approved drug targets | 1 | Acute myeloid leukaemiaBreast cancerKaposi sarcoma | Adhesion and uptake mediationClinical-translation mediationImmune mediation | 7 | 0.63 | ||
| XRN1 | Q8IZH2 | 5'-3' exoribonuclease 1 (EC 3.1.13.-) (Strand-exchange protein 1 homolog) | Essential proteinsPredicted intracellular proteins | Clinical-translation mediation | 7 | 0.63 | ||||
| AA1R | P30542 | Adenosine receptor A1 | FDA approved drug targetsG-protein coupled receptorsPredicted membrane proteins | 7 | Acute diabete complicationAllergic/hypersensitivity disorderCardiac arrhythmia | Clinical-translation mediationFusion and delivery mediationImmune mediation | 6 | 0.63 | ||
| ANO10 | Q9NW15 | Anoctamin-10 (Transmembrane protein 16K) | Disease related genesHuman disease related genesPotential drug targets | 8 | Clinical-translation mediationFusion and delivery mediation | 6 | 0.63 | |||
| ARHGC | Q9NZN5 | Rho guanine nucleotide exchange factor 12 (Leukemia-associated RhoGEF) | Cancer-related genesDisease related genesPredicted intracellular proteins | Receptor-signaling mediation | 6 | 0.63 | ||||
| CAH14 | Q9ULX7 | Carbonic anhydrase 14 (EC 4.2.1.1) (Carbonate dehydratase XIV) (Carbonic anhydrase XIV) (CA-XIV) | EnzymesFDA approved drug targetsMetabolic proteins | 1 | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 6 | 0.63 | |||
| CSF1R | P07333 | Macrophage colony-stimulating factor 1 receptor (CSF-1 receptor) (CSF-1-R) (CSF-1R) (M-CSF-R) (EC 2.7.10.1) (Proto-oncogene c-Fms) (CD antigen CD115) | Cancer-related genesCD markersDisease related genes | 1 | Alzheimer diseaseBone/articular cartilage neoplasmDiabetes mellitus | Clinical-translation mediationImmune mediationReceptor-signaling mediation | 6 | 0.63 | ||
| FGR | P09769 | Tyrosine-protein kinase Fgr (EC 2.7.10.2) (Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog) (Proto-oncogene c-Fgr) (p55-Fgr) (p58-Fgr) (p58c-Fgr) | Disease related genesEnzymesPlasma proteins | Clinical-translation mediationFusion and delivery mediationImmune mediation | 6 | 0.63 | ||||
| HRH1 | P35367 | Histamine H1 receptor (H1-R) (H1R) (HH1R) | FDA approved drug targetsG-protein coupled receptorsPredicted intracellular proteins | 7 | Clinical-translation mediationReceptor-signaling mediation | 6 | 0.63 |